Skip to content

Oculogica Portable EyeBOX Study

Oculogica Portable EyeBOX Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05047003
Acronym
RESTLESS
Enrollment
100
Registered
2021-09-16
Start date
2020-12-19
Completion date
2022-10-01
Last updated
2023-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concussion, Brain, Mild Traumatic Brain Injury

Brief summary

The objective of this study is to assess the accuracy of a portable version of the EyeBOX device, an eye-tracking based diagnostic, in comparison to a clinical reference standard of concussion. The utility of the portable assessment to aid in the monitoring of symptoms over time after an initial diagnosis of concussion will also be evaluated.

Interventions

DIAGNOSTIC_TESTEyeBOX Model EBX-4 (Portable version)

The portable EyeBOX takes less than 4 minutes to complete and involves watching a video move around the perimeter of an LCD monitor positioned in front of the patient while a high-speed camera continuously records gaze positions. The Portable EyeBOX software detects subtle changes in eye movements consistent with concussion and calculates a BOX score.

Sponsors

Oculogica, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 67 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Provide documented informed consent or assent along with guardian consent. * 2\. Have presented, at any time post injury, for any complaint related to an injury involving either a direct force to the head or a blow to the body that has the potential to transmit a rapid acceleration/deceleration of the head, with or without loss of consciousness, with or without external signs of head injury. * 3\. Be 5 to 67 years of age, inclusive. * 4\. Have the ability to provide a complete ophthalmologic, medical, and neurologic history as well as report current medications.

Exclusion criteria

* 1\. Have penetrating trauma or known skull fracture or intracranial injury. * 2\. Have had a conventional head CT or MRI demonstrating evidence of structural brain injury (subdural, epidural or intraparenchymal hemorrhage, edema/mass effect per attending radiologist read). * 3\. Any of the following conditions, immediately related to the incident injury: loss of consciousness exceeding 30 minutes or best available Glasgow Coma Scale (GCS) score less than 13 within 24 hours or other acute conditions requiring emergency medical management. * 4\. Be blind (no light perception), have missing or non-functional eyes. * 5\. Be unable to open their eyes. * 6\. Have a history of unresolved strabismus, diplopia, amblyopia. * 7\. Have a history of unresolved cranial nerve III, IV, or VI palsy. * 8\. Have a history of unresolved macular edema, retinal degeneration, extensive cataract, or ocular globe disruption. * 9\. Have a history of extensive prior eye surgery or scarring (examples include strabismus surgery, scleral buckle repair of retinal detachment, repair of blow out fractures of the orbit and any procedures that would interfere with extraocular muscle movements; prior cataract surgery or Lasik are not exclusions). * 10\. Have a prior history of unresolved ocular-motor dysfunctions. * 11\. Be intoxicated.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy of initial clinical diagnosis of concussionDay 0 (when patient first presents for evaluation)Sensitivity and Specificity compared to the initial diagnosis of concussion
Diagnostic accuracy of clinical diagnosis of post-concussion symptomsUp to one year after initial presentationSensitivity and Specificity compared to post-concussion symptoms
Adverse EventsThrough study participation, up to one yearAdverse events occurring during use of the diagnostic device

Secondary

MeasureTime frameDescription
Diagnostic accuracy to identify increases or decreases in post-concussion symptom severityUp to one year after initial presentationCorrelation with increases or decreases in post-concussion symptom severity
Subgroup analysesUp to one year after initial presentationSubgroup analyses will be performed by age, gender, and days since incident injury
Diagnostic accuracy of initial clinical diagnosis of concussionDay 0 (when patient first presents for evaluation)Positive and negative predictive value compared to initial clinical diagnosis of concussion

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026